NCT02151773View on ClinicalTrials.gov

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

CompletedOBSERVATIONAL
Enrollment

3,493

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Measles/Rubella
Interventions
DRUG

Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)

Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02151773 - Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination | Biotech Hunter | Biotech Hunter